Resistance to macrolide, lincosamide, streptogramin, ketolide, and oxazolidinone antibioticsROBERTS, Marilyn C.Molecular biotechnology. 2004, Vol 28, Num 1, pp 47-62, issn 1073-6085, 16 p.Article

The dissolution and bioavailability of rifampicin products in healthy subjects and tubercular patientsSHINOZAWA, S; YOSHIMURA, A; ARAKI, Y et al.Research communications in chemical pathology and pharmacology. 1983, Vol 42, Num 1, pp 161-164, issn 0034-5164Article

Biosynthetic origins of the large macrolide, oligomycin ABÚ'LOCK, J. D; MORRIS, G. A; RICHARDS, M. K et al.Tetrahedron letters. 1986, Vol 27, Num 25, pp 2917-2920, issn 0040-4039Article

The synthesis and antibacterial activity of tetracyclic macrolidesKASHIMURA, Masato; ASAKA, Toshifumi; SUZUKI, Keiko et al.Journal of antibiotics (Tokyo. 1968). 2003, Vol 56, Num 12, pp 1062-1065, issn 0021-8820, 4 p.Article

Hybrid biosynthesis of a new macrolide antibiotic by a daunomycin-producing microorganismSADAKANE, N; TANAKA, Y; OMURA, S et al.Journal of antibiotics (Tokyo. 1968). 1983, Vol 36, Num 7, pp 921-922, issn 0021-8820Article

ACUTE GONOCOCCAL URETHRITIS: TREATMENT WITH A SINGLE DOSE OF RIFAMPICINBELLI L; AMBRONA MS; GENNARO EA et al.1983; JOURNAL OF INTERNATIONAL MEDICAL RESEARCH; ISSN 0300-0605; GBR; DA. 1983; VOL. 11; NO 1; PP. 32-37; BIBL. 18 REF.Article

Voltammetric investigation of macrolides by an HPLC-coulometric assayKIM, Yong-Hak; POTHULURI, Jairaj V; CERNIGLIA, Carl E et al.Journal of pharmaceutical and biomedical analysis. 2005, Vol 38, Num 3, pp 390-396, issn 0731-7085, 7 p.Article

Clarithromycin inhibits fibroblast migrationKOHYAMA, Tadashi; YAMAUCHI, Yasuhiro; TAKIZAWA, Hajime et al.Respiratory medicine. 2008, Vol 102, Num 12, pp 1769-1776, issn 0954-6111, 8 p.Article

Enantioselective Synthesis of Aspergillide BNAGASAWA, Tomohiro; KUWAHARA, Shigefumi.Bioscience, biotechnology, and biochemistry. 2009, Vol 73, Num 8, pp 1893-1894, issn 0916-8451, 2 p.Article

Genetic engineering of macrolide biosynthesis: past advances, current state, and future prospectsSUNG RYEOL PARK; AH REUM HAN; BAN, Yeon-Hee et al.Applied microbiology and biotechnology. 2010, Vol 85, Num 5, pp 1227-1239, issn 0175-7598, 13 p.Article

Establishment of a Fast Chemical Identification System for screening of counterfeit drugs of macrolide antibioticsHU, Chang-Qin; ZOU, Wen-Buo; HU, Wang-Sheng et al.Journal of pharmaceutical and biomedical analysis. 2006, Vol 40, Num 1, pp 68-74, issn 0731-7085, 7 p.Article

Clinical implications of the immunomodulatory effects of macrolidesTAMAOKI, Jun; KADOTA, Junichi; TAKIZAWA, Hajime et al.The American journal of medicine. 2004, Vol 117, Num 9A, pp 5S-11S, issn 0002-9343Conference Paper

Rapamycin : Clinical results and future opportunitiesKAHAN, Barry D; CAMARDO, Joseph S.Transplantation. 2001, Vol 72, Num 7, pp 1181-1193, issn 0041-1337Article

Les macrolides = The macrolidesVINCENT, S; VISENT, C.Lyon pharmaceutique. 1996, Vol 47, Num 5, pp 240-252, issn 0024-7804Article

Zithromax : generic name : azithromycinMALLARKEY, G.Current therapeutics. 1995, Vol 36, Num 6, pp 101-103, issn 0311-905XArticle

Les macrolides chez l'adulte = Macrolids therapy in adultsMOUTON, Y; MAILLARD, C.Concours médical (Paris). 1995, Vol 117, Num 25, pp 1962-1963, issn 0010-5309Article

Macrolide progressWISE, R.Journal of antimicrobial chemotherapy (Print). 1990, Vol 26, Num 1, pp 5-6, issn 0305-7453, 2 p.Article

Antibiotiques. III: Aminosides, macrolides, rifamycines, vancomycine, imidazoles, cotrimoxazole = Antibiotics. III: Aminoglycosides, macrolides , rifamycines, vancomycin, imidazoles, cotrimoxazoleLa Revue du praticien (Paris). 1988, Vol 38, Num 16, pp 987-1043, issn 0035-2640, 48 p.Serial Issue

Pharmacopœial procedure for the determination of tylosin factors by high-performance liquid chromatographyFISH, B. J; CARR, G. P. R.Journal of chromatography. 1986, Vol 353, pp 39-50, issn 0021-9673Conference Paper

Fotometrische Bestimmung des Makrolid-Antibioticums Turimycin = Détermination photométrique de l'antibiotique macrolide turimycine = Photometric determination of the macrolide antibiotic turimycineHESSE, G.Pharmazie. 1984, Vol 39, Num 11, pp 775-776, issn 0031-7144Article

Fermentation conditions for the production of erythromycin by Streptomyces erythreusSINGH, M. P; ROY, D. K; MANDAL, S. K et al.Indian Journal of Microbiology. 1982, Vol 22, Num 2, pp 149-150, issn 0046-8991Article

Expression of the mphB gene for macrolide 2'-phosphotransferase II from Escherichia coli in Staphylococcus aureusNOGUCHI, N; TAMURA, Y; KATAYAMA, J et al.FEMS microbiology letters. 1998, Vol 159, Num 2, pp 337-342, issn 0378-1097Article

Identification of Escherichia coli clinical isolates producing macrolide 2'-phosphotransferase by a highly sensitive detection methodTANIGUCHI, K; NAKAMURA, A; TSURUBUCHI, K et al.FEMS microbiology letters. 1998, Vol 167, Num 2, pp 191-195, issn 0378-1097Article

Clinical experience with everolimus (certican) : A summaryPONTICELLI, Claudio.Transplantation. 2005, Vol 79, Num 9, pp S93-S94, issn 0041-1337, SUPArticle

Clinical implications of macrolide therapy in chronic sinopulmonary diseases : Novel Immunomodulatory Effects of Macrolides in Inflammatory Lung DiseaseMARTINEZ, Fernando J; SIMON, Richard H.Current pharmaceutical design. 2004, Vol 10, Num 25, pp 3095-3110, issn 1381-6128, 16 p.Article